Tag Archives: EFGSY

learn about the stock market

A tech pioneer is working with the marijuana industry for its latest marketing effort. That’s just one sign of pot’s mainstream acceptance, which could help propel the industry to 200% growth by 2020…

According to an Aug. 26, 2017, Rolling Stone report, Netflix Inc. (Nasdaq: NFLX) created a line of cannabis tied to the streaming service’s exclusive TV series.

The “Netflix Collection” debuted at a pop-up event in Los Angeles between Aug. 26 and Aug. 27. There were 10 different marijuana strains available, inspired by shows like “Arrested Development,” “Orange Is the New Black,” and “Bojack Horseman,” to name a few.

learn about the stock market: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

learn about the stock market: DepoMed Inc.(DEPO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Depomed Inc (NASDAQ: DEPO) got a boost, shooting up 13 percent to $23.90. Depomed is preparing to put itself up for sale, following calls from activist investor Starboard Value LP to explore such a move, just a year after it fought off a hostile acquisition bid, people familiar with the matter told Reuters.

learn about the stock market: Tesoro Corporation(TSO)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    U.S. oil refiner Tesoro (NYSE: TSO) said it would buy Western Refining (NYSE: WNR) for $4.1 billion to add refineries in Texas, New Mexico and Minnesota. The combined company will have refining capacity of over 1.1 million barrels per day. Tesoro has refineries in California, Washington, Alaska, Utah and North Dakota.

learn about the stock market: Rowan Companies Inc.(RDC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Go back a year, and offshore drillers like Noble (NE), Rowan (RDC), Transocean (RIG) and Atwood Oceanics (ATW) had been all but written off–until they weren’t anymore. Since then, investors have been rewarded for picking winners in the group from the losers, as Atwood Oceanics has more than doubled, Transocean has gained 34%, and Rowan has risen 42%, while Noble and Diamond Offshore Drilling (DO) have dropped 13%.

  • [By Jon C. Ogg]

    Rowan Companies plc (NYSE: RDC) closed up 15.1% at $17.84 and the 5.2 million shares traded was just 1.3 times normal trading volume. Rowan has a consensus analyst price target of $15.04 and a 52-week trading range of $10.67 to $20.88. The company has a total market cap of $2.2 billion.

trading on the stock market

August 3, 2017: Here are four stocks trading with heavy volume among 159 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by about 17 to 13 and on the Nasdaq decliners led advancers by a about 17 to 12.

Teva Pharmaceuticals Industries Inc. (NYSE: TEVA) dropped about 25% Thursday to register a new 52-week low of $23.33 after closing at $31.25 on Wednesday. The 52-week high is $55.79. Volume was nearly 97 million, nearly 8 times the daily average. The company reported a second-quarter loss and slashed its outlook as competition is cutting into revenue.

CenturyLink Inc. (NYSE: CTL) posted a new 52-week low of $21.62 on Thursday, down about 8.9% from Wednesday’s closing price of $23.74. The stock’s 52-week high is $33.45. Volume totaled around 20 million shares, double the daily average of around 10 million. The telecom firm missed expectations this morning and lowered guidance — a potent one-two punch to the stock price.

trading on the stock market: iShares Intermediate Credit Bond (CIU)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of ARKANSAS FINANCIAL GROUP, INC.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ARKANSAS+FINANCIAL+GROUP%2C+INC.

    These are the top 5 holdings of ARKANSAS FINANCIAL GROUP, INC.SPDR Dow Jones Industrial Average (DIA) – 257,721 shares, 25.79% of the total portfolio. Shares added by 0.48%iShares Core S&P Mid-Cap (IJH) – 269,365 shares, 22.36% of the total portfolio. Shares added by 0.51%iShares 1-3 Year Credit Bond (CSJ) – 375,399 shares, 19.16% of the total portfolio. Shares added by 8.03%iShares Intermediate Credit Bond (CIU) – 258,147 shares, 13.64% of the total portfolio. Shares added by 1.50%Vanguard Mid-Cap ETF – DNQ (VO)

trading on the stock market: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

trading on the stock market: Vanguard FTSE Developed Markets ETF (VEA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of P-Solve Investments Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=P-Solve+Investments+Ltd

    These are the top 5 holdings of P-Solve Investments LtdVanguard S&P 500 (VOO) – 4,400,097 shares, 39.56% of the total portfolio. Shares added by 7.03%Vanguard FTSE Developed Markets (VEA) – 13,317,140 shares, 22.4% of the total portfolio. Shares added by 99.57%iShares Core S&P Small-Cap (IJR) – 6,494,318 shares, 18.51% of the total portfolio. Shares added by 0.65%SPDR S&P 500 (SPY) – 669,450 shares, 6.55% of the total portfolio. Shares reduced by 12%Vanguard Total Stock Market (VTI) – 939,233 shares, 4.73% of th

trading on the stock market: Atkore International Group Inc. (ATKR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Spencer Israel]

    3. Atkor International Group Inc (NYSE: ATKR) – Five of the six analyst ratings on the manufacturing holding company have been bullish. With the stock showing very strong technical support at $16, and currently trading at $16.68, Stockal's confidence meter is at 90%. 

trading on the stock market: Caesars Acquisition Company(CACQ)

Advisors’ Opinion:

  • [By Travis Hoium]

    The big unknown with Caesars Entertainment is how the company’s proposed acquisition of Caesars Acquisition Company (NASDAQ:CACQ) and the resolution of Caesars Entertainment Operating Company’s bankruptcy will end up.

Top 5 Stocks To Own Right Now

The mainstream media basically brainwashed most Americans into thinking bitcoin was a scam.

Dont expect the mainstream media to show you how to make a fortune from new tech trends, including digital currencies. Theyre always late to the party.

In 1994, for example, the morning show NBC’s Today had a segment where one of the anchors asked, What is the internet, anyway?

In June 1998, mainstream economist Paul Krugman predicted the internets impact on the economy would be no greater than the fax machine.

I could go on and on.

But while the establishment was dismissing the technology as a fad, early adopters like myself were heavily investing in it and making fortunes.

The same thing is happening with cryptocurrencies.

Capitalism is 100% about innovation. The famous invisible hand has been written about since the 1700s. It guides capitalism through all the ups and downs of the economy, through depressions, recessions, wars, and so on.

Top 5 Stocks To Own Right Now: Avnet, Inc.(AVT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tech Data Corporation (NASDAQ: TECD) reached a deal with Avnet, Inc. (NYSE: AVT) enabling it to buy the latter's Technology Solutions business. The transaction comprises cash component of $2.4 billion and 2.785 million shares of Tech Data resulting in a total value of about $2.6 billion.

Top 5 Stocks To Own Right Now: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

Top 5 Stocks To Own Right Now: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Top 5 Stocks To Own Right Now: Ubiquiti Networks, Inc.(UBNT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, technology shares rose by just 0.2 percent. Meanwhile, top losers in the sector included Ubiquiti Networks Inc (NASDAQ: UBNT), down 14 percent, and Magnachip Semiconductor Corp (NYSE: MX), down 12 percent.

  • [By Steve Symington]

    Shares of Ubiquiti Networks Inc.(NASDAQ:UBNT) were down 13.4% as of 1:30 p.m. EST Friday after the networking hardware company released mixed fiscal second-quarter 2017 results.

  • [By Jim Robertson]

    On Monday, small cap Ubiquiti Networks (NASDAQ: UBNT) fell 7.89%after notorious short seller Andrew Left/Citron Research issued a report calling the stock a fraud, but shares were regainingsome of what was lost in early Tuesdaytrading. Ubiquiti Networkseliminates barriers to connectivity for under-networked enterprises, communities and consumers with its leading-edge platforms that connect hundreds of millions of people throughout the world. With over 60 million devices sold worldwide, through a network of over 100 distributors, to customers in more than 180 countries and territories,the Companyhas maintained an industry-leading financial profile by leveraging a unique business model to develop products that combine innovative technology with disruptive price-to-performance characteristics.Growth is supported by the Ubiquiti Community, a global grass-roots community of 4 million entrepreneurial operators and systems integrators who engage in thousands of forums.

  • [By Peter Graham]

    Mid cap network communication platform makerUbiquiti Networks Inc (NASDAQ: UBNT) reportedfiscal Q4 2017 earnings before the market opened with shares surging 16.56% when the market closed. Revenues increased 23% year-over-year and 4.7% sequentially to $228.6 million, primarily driven by continued strong demand for new product offerings across the Company’s product lines. Enterprise Technology revenues increased 49% year-over-year, primarily driven by continued adoption of the Company’s UniFi product family of access points, switches, gateways and IP cameras.Service Provider Technology revenues increased 5% year-over-year and 10% sequentially, primarily driven by the Company’s airMAX AC and airMAX AC Gen 2 product lines. GAAP Net Income was $60.7 million versus $57.7 million. Total cash and cash equivalents as of June 30, 2017 were $604.2 million versus $533.9 million as of March 31, 2017, representing an increase of over 13%.

Top 5 Stocks To Own Right Now: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Lowe's Companies, Inc. (NYSE: LOW) reported better-than-expected results for its third quarter.

    Lowe's reported Q3 earnings of $1.05 per share on revenue of $16.77 billion. However, analysts were expecting a profit of $1.03 per share on sales of $16.59 billion. Its comparable sales gained 5.7 percent during the quarter.

  • [By Peter Graham]

    A long term performance chart for Lumber Liquidators Holdings showstabilization with a slight uptick over the past two years while large capsThe Home Depot, Inc (NYSE: HD)and Lowe’s Companies, Inc (NYSE: LOW) have been much more steady performers:

  • [By WWW.THESTREET.COM]

    In the battle for your dollars, there have been obvious winners, Cramer said, as Home Depot (HD) trounced Lowe’s (LOW) , and Target (TGT) beat Walmart (WMT) . Meanwhile, both Ross Stores (ROST) and TJX Stores (TJX) saw tremendous growth.

  • [By Teresa Rivas]

    Lowes(LOW) soared on Wednesday after reporting fourth-quarter earnings, making it the best performer in the S&P 500.

    Getty Images

    Today the shares are lower, but RBC Capital Markets’Scot Ciccarelli writes that the quarter’s strength supports more gains ahead.

    Ciccarelli and his team reiterated an Outperform rating on the stock and raised their price target $7, to $90, writing that the sales trends are positive and the macro backdrop, including a robust housing and construction sector, remains supportive for Lowe’s. They still preferHome Depot(HD), saying it provides more consistent execution, but are upbeat about Lowe’s ability to keep climbing.

    Details from their note about Lowe’s upbeat same-store sales:

    Lowes monthly comps were very healthy, up 4.7%, 6.3% and 4.2% (Nov-Jan), compared to Home Depots 6.0%, 8.0%, 5.1%. Both comp ticket (+4%) and transaction growth (+1.1%) contributed to the comp after stalling in recent quarters (2Q and 3Q traffic growth were sub-1%). Further, 2-year transaction comps (which we view as the run-rate) improved to ~4.7% in 4Q from 3Qs 3.0% and 2Qs 1.3%. Comps in all regions and nearly all product categories were positive, and the Pro continued to comp above company average. Big-ticket was also strong (+9%), driven by categories such as Appliances, Kitchen and Lawn & Garden.

    Lowe’s is down down 0.9% to $80.70 in recent trading, although it’s up 13.5% since the start of the year.

  • [By WWW.THESTREET.COM]

    Williams-Sonoma (WSM) reported a mixed third quarter. Comparable-brand sales at Pottery Barn fell, while sales at West Elm continued to outpace its other brands. Home Depot (HD) lifted its full-year earnings estimates after strong sales growth in its third quarter. Lowe’s (LOW) fell short of third-quarter earnings and revenue estimates, while same-store sales growth of 2.7% missed analysts’ 3% target.

  • [By Michael K. Farr]

    The home-improvement sector, and Lowe’s in particular, we feel remains one of the few attractive areas in retail. LOW offers relative immunity from online competition, and the company’s economies of scale give it a competitive pricing advantage over smaller regional players. The company’s strong free cash flow and commitment to returning cash to shareholders through buybacks will continue to be accretive to EPS. Margins have been improving in recent years, but they continue to trail 2007 highs by a significant amount, which gives us confidence this trend can continue. We think LOW represents good value given our expectation for mid-teens EPS growth over the intermediate term. LOW also offers at 1.5 percent dividend yield and currently trades 19.3 times calendar year16 estimated EPS.  

Hot Medical Stocks To Watch Right Now

Health savings accounts are poised for a major expansion by Republicans in Washington, D.C., and that could mean millions more customers and fees flowing to a handful of companies.

Investors are betting on it, bidding up shares of HSA provider HealthEquity (HQY) by about 35% since the November election. It’s one of the best performing stocks on Wall Street since Donald Trump won the White House.

Another big beneficiary might be Optum Bank, the industry leader, with more than 3 million of these accounts and about $7 billion in assets it manages for consumers. It’s owned by the nation’s largest health insurer, UnitedHealth Group.

For years, these companies and others have been lobbying lawmakers for changes that could become reality with a Republican-controlled Congress and Trump administration.

The GOP health law replacement plan introduced Monday in the House reflects the party’s broad consensus for giving more Americans access to HSAs, which allow people to put aside money tax-free for medical expenses.

Hot Medical Stocks To Watch Right Now: SanDisk Corporation(SNDK)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Early on Friday, analysts at RBC Capital boosted the near-term estimates on SanDisk Corporation (SNDK), a manufacturer of data storage products, because a fire at SK Hynix’s factory should lead to favorable pricing over the next two quarters.

    “We see a favorable pricing environment as a result of SK Hynix’s fire, which threatens to curtail NAND output as the company likely re-purposes production back toward DRAM, resulting in lower than expected incremental NAND wafers vs. company’s plan of 170K/WPM,” RBC Capital analyst Freedman said. “Consequently, we see stronger pricing through EoY before SK Hynix ramps NAND toward normalized prod’t levels as DRAM resources are restored/replaced.”

    The analysts maintain an “Outperform” rating on SDNK and still see shares reaching $76. This price target suggests a 26% upside to the stock’s Thursday closing price of $60.08. Furthermore, they boosted SanDisk’s 2013 EPS estimates from $4.82 to $4.95.

    SanDisk shares were up a fraction during pre-market trading on Friday. The stock is up 38.11% year-to-date.

Hot Medical Stocks To Watch Right Now: KeyCorp(KEY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    But then there was good news from rail transport company CSX (CSX ) , which saw growth in every one of its business lines. Foot Locker (FL) also surprised to the upside, sending shares up a quick 5.3%. Cramer fave and Action Alerts PLUS holding KeyCorp (KEY) also delivered, as did paint maker Sherwin-Williams (SHW) .

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed big options volume in the December weekly, 18 strike calls in KeyCorp (NYSE: KEY). He decided to follow the trade and he is going to hold the position for 1 to 2 days.

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Hot Medical Stocks To Watch Right Now: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Hot Medical Stocks To Watch Right Now: Delcath Systems Inc.(DCTH)

Advisors’ Opinion:

  • [By Money Morning News Team]

    If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

  • [By Paul Ausick]

    Delcath Systems Inc. (NASDAQ: DCTH) dropped nearly 44% Friday to post a new 52-week low of $0.46 after closing Thursday at $0.82. The 52-week high is $8.80. Volume of around 4.5 million was more than 20 times the daily average of around 280,000 shares traded. The company had no specific news.

Top 5 Bank Stocks To Own For 2018

President-elect Donald Trump has tapped Steven Mnuchin, a former Goldman Sachs Group Inc. (NYSE: GS) partner and active movie financier, to be the new Treasury secretary of the United States.

This means the 53-year-old one-time Wall Street banker will soon be the new face of the U.S. economy. And as such, he will cosign our currency, collect our taxes, manage the nation’s debt, and oversee banking regulations.

Keeping these major responsibilities in mind, however, prompted several pundits and politicians to speak out in protest of Mnuchin’s appointment. These critics claimed that such duties can’t be objectively carried out by a former “big banker.” And they took to the Internet to voice their concerns.

Top 5 Bank Stocks To Own For 2018: KeyCorp(KEY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By WWW.THESTREET.COM]

    But then there was good news from rail transport company CSX (CSX ) , which saw growth in every one of its business lines. Foot Locker (FL) also surprised to the upside, sending shares up a quick 5.3%. Cramer fave and Action Alerts PLUS holding KeyCorp (KEY) also delivered, as did paint maker Sherwin-Williams (SHW) .

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed big options volume in the December weekly, 18 strike calls in KeyCorp (NYSE: KEY). He decided to follow the trade and he is going to hold the position for 1 to 2 days.

Top 5 Bank Stocks To Own For 2018: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Bank Stocks To Own For 2018: Manitowoc Company, Inc. (The)(MTW)

Advisors’ Opinion:

  • [By Ben Levisohn]

    With a neutral sector rating, we are working on evaluating risks to negative calls, and identifying potential value opportunities. Last week we noted more work might be worthwhile on Wabco Holdings (WBC), Terex, Manitowoc (MTW), and Caterpillar, two of those names have rallied for other reasons but the attractive price made the upside/downside skew up. We remain positive (OW) on Allison Transmission Holdings (ALSN) & United Rentals. Our and consensus 2017Allison Transmission Holdings estimates have fallen by 2% vs. ~15% for the group, while the shares are down 10% since launch. We continue to see United Rentals as the best value in our group…

Top 5 Bank Stocks To Own For 2018: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Top 5 Bank Stocks To Own For 2018: Porter Bancorp Inc.(PBIB)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 27.82% of the total portfolio. Guaranty Bancorp (GBNK) – 1,891,767 shares, 23.36% of the total portfolio. Shares reduced by 19.22%Meta Financial Group Inc (CASH) – 347,069 shares, 14.02% of the total portfolio. Sterling Bancorp (STL) – 1,048,980 shares, 11.07% of the total portfolio. Shares reduced by 16.01%MBT Financial Corp (MBTF) – 2,060,302 sha

Top Medical Stocks To Buy Right Now

Allegations that Mylan (MYL) overcharged the government for EpiPens have put specialty pharmaceutical companies like Endo International (ENDP), Valeant Pharmaceuticals International (VRX), and Mallinckrodt (MNK) under pressure today, as drug pricing proves to be the source of pain that just won’t go away. Guggenheim’s Louise Chen and team discuss the takeaways from a Henry Kaiser Family Foundation call yesterday that focused on the drug pricing controversy:

Getty Images

We highlight the key takeaways below, which have read-throughs for brand drug companies we cover such asAllergan (AGN), Shire (SHPG), Valeant Pharmaceuticals International, Mallinckrodt,Endo International and Jazz Pharmaceuticals (JAZZ), among others.

What needs to be fixed? Access to drugs is the biggest problem. The Washington Post had a study on Gleevec (used to treat Hep C) showing that a lot of people are not getting access to Gleevec who need it. The problem is more about access versus high drug costs. Deductibles have gone up so it’s hard for patients to afford the drugs they need. That said, if Hep C is treated, the U.S. has an ability to eradicate the disease like polio. That is a big benefit for society. So, Hep C is not a value issue, it’s about the cost of the upfront investment. The answer may be to tie reimbursement to infection rates and liver transplants. Payors could then ensure access and spread out payments on performance-based contracts. Therefore, if the drug really works, the company will make a lot of money. One potential issue with doing this is that the rules in Medicaid dictate that they get the best price. Medicaid can argue the price is free because the payment is in the future and this can provide a regulatory and legal challenge. Another way to ensure access is to pay drug companies a dollar amount to cover the entire patient population versus just a certain percentage of the population. For example, a company gets $10B to take care of everyone. One of the panelists noted that there is a big misconception about what is driving healthcare costs and this could lead to problematic policy choices, which could deter innovation for drugs. When patients are asked if they want the lowest medical cost or access to a wider array of treatment options, people generally prefer choice. If that’s the case, then there is no free lunch. Someone has to pay for innovation.

Top Medical Stocks To Buy Right Now: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

  • [By Roberto Pedone]

    Uni-Pixel (UNXL) manufactures electronic film products using its proprietary manufacturing process, UniBoss. This stock closed up 7.6% to $16.84 in Monday’s trading session.

    Monday’s Volume: 1.88 million

    Three-Month Average Volume: 1 million

    Volume % Change: 108%

    From a technical perspective, UNXL bounced sharply higher here right off its 50-day moving average of $15.89 with above-average volume. This stock looks to be forming a double bottom chart pattern at $14.91 to $15.16. If that bottom holds, then shares of UNXL could see a continuation of Monday’s upside action.

    Traders should now look for long-biased trades in UNXL as long as it’s trending above $15.16 or $14.91 and then once it sustains a move or close above Monday’s high of $17.53 with volume that hits near or above 1 million shares. If we get that move soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $19.89.

  • [By Lisa Levin]

    Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

  • [By Peter Graham]

    Small cap sensor film stock UniPixel Inc (NASDAQ: UNXL) is sinking by a double digit percentage in after-hours and pre-market trading after reporting Q4 earnings. The problem for UniPixel is that only a few analysts cover the small cap stock and the bottom line loss was a bit worst than the 10 cent loss they were expecting. The stock also had a slight uptick ahead of earnings:

Top Medical Stocks To Buy Right Now: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Top Medical Stocks To Buy Right Now: Brown(n)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

Top Medical Stocks To Buy Right Now: Access National Corporation(ANCX)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, ourunder the Radar Moversnewsletter suggestedshorting small cap Northern Virginia based bank holding stock Access National Corporation (NASDAQ: ANCX):

Top Medical Stocks To Buy Right Now: BioAmber Inc.(BIOA)

Advisors’ Opinion:

  • [By Markus Aarnio]

    BioAmber (BIOA) is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.

  • [By Paul Ausick]

    BioAmber Inc. (NYSE: BIOA) dropped nearly 29% Friday to post a new 52-week low of $2.24 after closing Thursday at $3.14. Volume of more than 1.5 million shares was about 6 times the daily average of around 240,000. The company’s annual report, filed on Thursday with its quarterly results, included a “going concern” statement from the company’s independent auditing firm.

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

  • [By Lisa Levin]

    Bioamber Inc (NYSE: BIOA) shares dropped 19 percent to $2.55. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top Medical Stocks To Buy Right Now: Resolute Energy Corporation(REN )

Advisors’ Opinion:

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

  • [By Elizabeth Balboa]

    The activist hedge fund’s latest 13F revealed a stake in Resolute Energy Corp (NYSE: REN), and on Monday, it announced a new position in EQT Corporation (NYSE: EQT).

  • [By WWW.THESTREET.COM]

    Or how about Resolute Energy (REN) , which has a big position in the Permian. Why is that stock not quitting? Same with Diamondback Energy (FANG) . How can that one keep roaring?

  • [By Ezra Schwarzbaum]

    Related Links: Magellan Midstream Riding The Wave Of Rising US Oil Exports

    Resolute Energy Corp (NYSE: REN), $40 Price Target

    Moving into the late-2014 downturn, Resolute had an over-levered balance sheet, flat production and a wide geographical spread.